{
    "drug_class_values": "alkyl sulfonates , cd22 (clusters of differentiation 22) inhibitors , egfr (epidermal growth factor receptor) inhibitors , detoxifying agents for antineoplastic treatment , other antithrombotic agents , cd38 (clusters of differentiation 38) inhibitors , various therapeutic radiopharmaceuticals , enzymes , other hematological agents , other immunostimulants , various alimentary tract and metabolism products , antivirals , epidermal growth factor receptor (egfr) tyrosine kinase inhibitors , bcr-abl tyrosine kinase inhibitors , other immunosuppressants , selective immunosuppressants , other plant alkaloids and natural products , other hormone antagonists and related agents , preparations increasing uric acid excretion , other protein kinase inhibitors , vascular endothelial growth factor receptor (vegfr) tyrosine kinase inhibitors , proteasome inhibitors , anti-androgens , antineoplastic cell and gene therapy , fourth-generation cephalosporins , vegf/vegfr (vascular endothelial growth factor / -receptor) inhibitors , cd20 (clusters of differentiation 20) inhibitors , anti-estrogens , nan , antineovascularisation agents , her2 (human epidermal growth factor receptor 2) inhibitors , other monoclonal antibodies and antibody drug conjugates , hedgehog pathway inhibitors , other antianemic preparations , combinations of antineoplastic agents , pd-1/pd-l1 (programmed cell death protein 1/death ligand 1) inhibitors , combinations of monoclonal antibodies and antibody drug conjugates , anaplastic lymphoma kinase (alk) inhibitors , b-raf serine-threonine kinase (braf) inhibitors , poly (adp-ribose) polymerase (parp) inhibitors , fibroblast growth factor receptor (fgfr) tyrosine kinase inhibitors , phosphatidylinositol-3-kinase (pi3k) inhibitors , other antineoplastic agents , pyrimidine analogues , janus-associated kinase (jak) inhibitors , bruton's tyrosine kinase (btk) inhibitors , cyclin-dependent kinase (cdk) inhibitors , colony stimulating factors , isocitrate dehydrogenase (idh) inhibitors , other drugs affecting bone structure and mineralization , aromatase inhibitors , monoclonal antibodies , interleukin inhibitors , interferons , human epidermal growth factor receptor 2 (her2) tyrosine kinase inhibitors , histone deacetylase (hdac) inhibitors , mitogen-activated protein kinase (mek) inhibitors"
    ,"drug_indication_values":  "migraine, hidradenitis suppurativa , small cell lung cancer , neuromyelitis optica spectrum disorder , bullous pemphigoid , mantle cell lymphoma , gastric or gastro-esophageal junction adenocarcinoma , merkel cell carcinoma , solid tumors , basal cell carcinoma , b-cell precursor acute lymphoblastic leukemia , uveal melanoma , non-squamous non-small cell lung cancer , tumor mutational burden-high solid tumors , advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer , light chain (al) amyloidosis , crohn's disease , osteoporosis , urothelial carcinoma , eosinophilic esophagitis , polymyalgia rheumatica , cutaneous t-cell lymphoma , non-muscle invasive bladder cancer , methotrexate toxicity , metastatic gastric adenocarcinoma , neovascular age-related macular degeneration , kaposi sarcoma , spinal muscular atrophy , gastric cancer , esophageal squamous cell carcinoma , gastric or gastroesophageal junction adenocarcinoma , gastrointestinal stromal tumor , endometrial cancer , ulcerative colitis , giant cell tumor of bone , melanoma , non-myeloid malignancies , marginal zone lymphoma , synovial sarcoma , metastatic colorectal cancer , pheochromocytoma or paraganglioma , biliary tract cancer , tenosynovial giant cell tumor , sickle cell disease , lupus nephritis , low-grade glioma , advanced systemic mastocytosis , chronic lymphocytic leukemia or small lymphocytic lymphoma , neuroendocrine tumors , acute lymphoblastic leukemia , cytokine release syndrome , neuroblastoma , macular edema , colorectal cancer , nonmuscle invasive bladder cancer , chronic obstructive pulmonary disease , cholangiocarcinoma , solid tumors with ntrk gene fusion , esophageal cancer , systemic juvenile idiopathic arthritis , hypercalcemia of malignancy , myelodysplastic syndromes with ring sideroblasts or myelodysplastic/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis , differentiated thyroid cancer , mast cell leukemia , malignant pleural mesothelioma , medullary thyroid cancer , squamous cell carcinoma of the oral cavity , large b-cell lymphoma , small lymphocytic lymphoma , enthesitis-related arthritis , mismatch repair deficient recurrent or advanced solid tumors , von hippel-lindau disease , hepatic veno-occlusive disease (vod) / sinusoidal obstruction syndrome (sos) , β-thalassemia , microsatellite instability-high or mismatch repair deficient colorectal cancer , alzheimer's disease , indolent systemic mastocytosis , aggressive systemic mastocytosis , acute myeloid leukemia , squamous non-small cell lung cancer , pancreatic cancer , epithelioid sarcoma , prurigo nodularis , atopic dermatitis , nasopharyngeal carcinoma , autologous hematopoietic progenitor cell mobilization , achondroplasia , pediatric low-grade glioma , plaque psoriasis , neurofibromatosis type 1 , beta thalassemia , breast cancer , severe chronic neutropenia , myelodysplastic syndromes , uncomplicated urinary tract infection , granulomatosis with polyangiitis and microscopic polyangiitis , myeloid/lymphoid neoplasms , rheumatoid arthritis , duchenne muscular dystrophy , bladder cancer , histiocytic neoplasms , non-hodgkin's lymphoma , waldenström's macroglobulinemia , alveolar soft part sarcoma , polyarticular juvenile idiopathic arthritis , hematopoietic subsyndrome of acute radiation syndrome , chronic lymphocytic leukemia / small lymphocytic lymphoma , myelodysplastic syndrome , cervical cancer , asthma , diffuse large b-cell lymphoma and high-grade b-cell lymphoma , cognitive impairment , multicentric castleman's disease , beta-thalassemia , chronic myeloid leukemia , liposarcoma , transthyretin-mediated amyloidosis , non-radiographic axial spondyloarthritis , chronic lymphocytic leukemia , chronic graft-versus-host disease , glioblastoma , chronic rhinosinusitis with nasal polyps , renal cell carcinoma , bone loss due to androgen deprivation therapy , lung cancer , desmoid tumor , giant cell arteritis , glucocorticoid-induced osteoporosis , lymphoblastic lymphoma , non-myeloid malignancy , hereditary transthyretin-mediated amyloidosis , ovarian cancer , triple-negative breast cancer , myelofibrosis , coronavirus disease 2019 , metastatic renal cell carcinoma , friedreich's ataxia , grade 2 astrocytoma or oligodendroglioma , ankylosing spondylitis , carcinoid syndrome diarrhea , waldenström’s macroglobulinemia , head and neck squamous cell carcinoma , leiomyosarcoma , prostate cancer , acute graft versus host disease , bone metastases from solid tumors , polycythemia vera , endometrial carcinoma , chronic myelogenous leukemia , diabetic retinopathy , cutaneous squamous cell carcinoma , coronary artery disease , systemic mastocytosis with associated hematological neoplasm , squamous cell carcinoma of the head and neck , recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer , multiple sclerosis , anaplastic thyroid cancer , bone loss due to aromatase inhibitor therapy , follicular lymphoma , high-risk smoldering multiple myeloma , multiple myeloma , microsatellite instability-high or mismatch repair deficient solid tumors , gastroenteropancreatic neuroendocrine tumors , thyroid cancer , hepatocellular carcinoma , epithelial ovarian cancer , peripheral t-cell lymphoma , urothelial cancer , nonmyeloid malignancies , diffuse large b-cell lymphoma , philadelphia chromosome-positive acute lymphoblastic leukemia , squamous cell carcinoma of the anal canal , blastic plasmacytoid dendritic cell neoplasm , chronic lymphocytic leukemia/small lymphocytic lymphoma , chronic spontaneous urticaria , diabetic macular edema , non-small cell lung cancer , psoriatic arthritis , acute leukemia , pemphigus vulgaris , hematopoietic syndrome of acute radiation syndrome"
    ,"drug_manufacturer_values": "mirati therapeutics, inc, exelixis, inc., acrotech biopharma inc, tanvex biopharma usa, inc., bluebird bio, inc., kadmon pharmaceuticals, llc, geron corporation, astellas pharma us, inc., organon llc, blueprint medicines corporation, coherus biosciences, inc., fresenius kabi usa, llc, blue earth diagnostics, beone medicines usa, inc., secura bio, inc, emd serono, inc., ge healthcare inc. (medi-physics, inc. dba ge healthcare), tg therapeutics, inc., united therapeutics corporation, boehringer ingelheim pharmaceuticals, inc., genzyme corporation, g1 therapeutics, inc., amgen inc, novartis gene therapies, inc., medexus pharma, inc., adc therapeutics america, inc., janssen products, lp, incyte corporation, regeneron pharmaceuticals, inc, takeda pharmaceuticals america, inc., eli lilly and company, astrazeneca pharmaceuticals lp, sarepta therapeutics, inc., merck sharp & dohme llc, sanofi-aventis u.s. llc, biogen, lumicell, inc., altor bioscience, llc, an indirect wholly-owned subsidiary of immunitybio, inc., daiichi sankyo inc., sumitomo pharma america, inc., u.s. pharmaceuticals, epizyme, inc., glaxosmithkline llc, e.r. squibb & sons, l.l.c. , vertex pharmaceuticals incorporated, deciphera pharmaceuticals, llc, celltrion usa, inc., y-mabs therapeutics, inc., celgene corporation, ge healthcare inc., cephalon, llc, pharmaessentia usa, genmab us, inc., recordati rare diseases, inc., adaptimmune llc, curium us llc, valorum biologics, llc, cordavis limited, coherus oncology, inc., citius pharmaceuticals, inc., gamida cell inc., sandoz inc, mesoblast, sun pharmaceutical industries, inc., onyx pharmaceuticals, inc., advanced accelerator applications usa, inc, cephalon, inc., progenics pharmaceuticals, inc., spectrum pharmaceuticals, inc., springworks therapeutics, inc., sobi, inc., akeso biopharma, co., ltd, amneal pharmaceuticals llc, servier pharmaceuticals llc, juno therapeutics, inc., jazz pharmaceuticals, inc., stemline therapeutics, inc., janssen biotech, inc., pharmacyclics llc, day one biopharmaceuticals, inc., tersera therapeutics llc, bayer healthcare pharmaceuticals inc., taiho pharmaceutical co., ltd., cardinal health 414, llc, accord biopharma inc., kite pharma, inc., syndax pharmaceuticals, inc., aveo pharmaceuticals, inc., kyowa kirin, inc., gilead sciences, inc., janssen products lp, puma biotechnology, inc., alnylam pharmaceuticals, inc., biomarin pharmaceutical inc., on target laboratories, inc., servier pharmaceutical llc, sandoz inc., regeneron pharmaceuticals, inc., genentech inc., biocon biologics inc., immunocore commercial llc, pharmaand gmbh, eisai inc., immunogen, inc., biogen inc., rigel pharmaceuticals, inc., iovance biotherapeutics inc., bio-thera solutions, ltd., btg international inc., iterum therapeutics us limited, genentech, inc., amgen, inc, novartis pharmaceuticals corporation, abbvie inc., seagen inc., janssen biotech, inc, ferring pharmaceuticals inc., viela bio, inc., pfizer laboratories div pfizer inc, array biopharma inc., "
}
      